Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- United Kingdom
- Portugal
- Netherlands
- Sweden
- Spain
- France
- Germany
- Denmark
- Norway
- United Arab Emirates
- Australia
- Belgium
- Poland
- Singapore
- Finland
- Italy
- Japan
- Luxembourg
- Morocco
- Switzerland
- Ireland
- Canada
- Czech
- Romania
- Saudi Arabia
- Worldwide
- Europe
- Hong Kong
- Lithuania
- Vietnam
- 21 more »
- « less
-
Program
-
Field
-
evaluate the therapeutic value of monoclonal GIPR antibodies both alone and in combination with known antidiabetic drugs and novel agents in development. Important Information: Applications for more than one